phrykt

Privia Health Group, Inc. (PRVA): who owns it and who trades it

As of Nov 16, 2026, PRVA insiders reported 40 open-market sales worth $22.2M and no purchases in the last 12 months, with 87% of the sale value made under pre-set 10b5-1 plans. The largest seller was Matthew Shawn Morris (Director), with $11.9M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Privia Health Group

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PRVA

301 funds and institutions reported PRVA shares worth $3.3B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 17.0%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.17.0%
FMR LLC (Fidelity)10.2%
Durable Capital Partners LP9.2%
Vanguard Portfolio Management LLC5.2%
Rubicon Founders LLC4.7%
Vanguard Capital Management LLC4.1%
State Street Corp3.9%
Van Berkom & Associates Inc.2.9%
Geode Capital Management, LLC2.5%
Riverbridge Partners LLC2.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.21.40M16.98%$551M+12%
FMR LLC (Fidelity)12.85M10.20%$331M-2%
Durable Capital Partners LP11.64M9.23%$299M-4%
Vanguard Portfolio Management LLC6.57M5.22%$169M+5%
Rubicon Founders LLC5.97M4.74%$154M+0%
Vanguard Capital Management LLC5.16M4.09%$133M+3%
State Street Corp4.91M3.89%$126M+9%
Van Berkom & Associates Inc.3.71M2.95%$95.5M-54%
Geode Capital Management, LLC3.13M2.48%$80.6M+8%
Riverbridge Partners LLC3.00M2.38%$77.2M-23%
Bank of New York Mellon Corp2.89M2.30%$74.4M-2%
California State Teachers Retirement System2.73M2.17%$106M+2771%
Principal Financial Group Inc2.59M2.05%$66.6M-5%
Dimensional Fund Advisors LP2.55M2.03%$65.7M+6%
Wellington Management Group LLP2.13M1.69%$54.8M+851%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1.95M1.55%$50.1M-5%
BlackBarn Capital Partners LP1.58M1.26%$40.8MNo change
Nuveen, LLC1.47M1.16%$37.7M+55%
Bank of America Corp1.43M1.14%$36.8M+14%
Charles Schwab Investment Management Inc1.37M1.09%$35.4M+4%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PRVA insiders reported $0 of open-market purchases and $22.2M of sales. 87% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$22.2M
40 trades, 4 people
Sales under a 10b5-1 plan
87%
Share of sale value
Latest trade
Jul 9, 2026
Filed Jul 13, 2026

Purchases and sales by month

$6.6M$6.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 9, 2026David MountcastleCFOSale plan21,275$27.67$589KForm 4
Jul 7, 2026David MountcastleCFOSale plan600$27.57$16.5KForm 4
Jul 6, 2026Matthew Shawn MorrisDirectorSale plan53,722$27.24$1.5MForm 4
Jul 2, 2026Matthew Shawn MorrisDirectorSale plan59,037$27.33$1.6MForm 4
Jul 2, 2026David MountcastleCFOSale plan24,734$27.50$680KForm 4
Jul 1, 2026Matthew Shawn MorrisDirectorSale plan37,041$26.93$998KForm 4
Jul 1, 2026Matthew Shawn MorrisDirectorSale plan45,634$26.52$1.2MForm 4
Jun 30, 2026Matthew Shawn MorrisDirectorSale plan52,823$25.72$1.4MForm 4
Jun 29, 2026Matthew Shawn MorrisDirectorSale plan63,212$25.33$1.6MForm 4
Jun 26, 2026Matthew Shawn MorrisDirectorSale plan88,110$25.33$2.2MForm 4
Jun 26, 2026David MountcastleCFOSale plan17,196$25.18$433KForm 4
May 12, 2026Parth MehrotraCEOSale plan15,647$22.64$354KForm 4
May 11, 2026Parth MehrotraCEOSale plan105,439$22.55$2.4MForm 4
May 11, 2026David MountcastleCFOSale3,385$22.60$76.5KForm 4
May 4, 2026David MountcastleCFOSale plan1,206$25.00$30.1KForm 4
May 4, 2026Matthew Shawn MorrisDirectorSale plan1,017$24.96$25.4KForm 4
May 1, 2026David MountcastleCFOSale plan7,179$25.03$180KForm 4
May 1, 2026Matthew Shawn MorrisDirectorSale plan17,096$24.99$427KForm 4
Apr 2, 2026David MountcastleCFOSale5,566$20.85$116KForm 4
Mar 16, 2026David MountcastleCFOSale6,391$22.11$141KForm 4
Mar 16, 2026Parth MehrotraCEOSale26,509$22.11$586KForm 4
Mar 13, 2026David MountcastleCFOSale6,565$21.52$141KForm 4
Mar 13, 2026Parth MehrotraCEOSale27,229$21.52$586KForm 4
Mar 12, 2026David MountcastleCFOSale6,453$21.90$141KForm 4
Mar 12, 2026Parth MehrotraCEOSale26,763$21.90$586KForm 4
Mar 10, 2026Parth MehrotraCEOSale plan21,097$22.71$479KForm 4
Mar 9, 2026Parth MehrotraCEOSale plan21,915$22.84$501KForm 4
Mar 9, 2026Parth MehrotraCEOSale plan18,865$22.84$431KForm 4
Mar 9, 2026Parth MehrotraCEOSale plan1,219$23.37$28.5KForm 4
Mar 9, 2026Edward C FargisVice presidentSale4,949$22.84$113KForm 4
Mar 9, 2026David MountcastleCFOSale5,829$22.84$133KForm 4
Mar 6, 2026Parth MehrotraCEOSale plan21,440$23.15$496KForm 4
Mar 6, 2026Edward C FargisVice presidentSale4,394$23.15$102KForm 4
Mar 6, 2026David MountcastleCFOSale5,177$23.15$120KForm 4
Feb 27, 2026Matthew Shawn MorrisDirectorSale plan16,550$25.00$414KForm 4
Feb 27, 2026David MountcastleCFOSale plan7,697$25.05$193KForm 4
Feb 26, 2026Matthew Shawn MorrisDirectorSale plan7,788$24.99$195KForm 4
Feb 26, 2026David MountcastleCFOSale plan5,361$25.00$134KForm 4
Dec 12, 2025Matthew Shawn MorrisDirectorSale plan13,647$25.01$341KForm 4
Dec 12, 2025David MountcastleCFOSale plan23,887$25.03$598KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Matthew Shawn MorrisDirector–$11.9MJul 6, 2026
Parth MehrotraChief Executive Officer, Director–$6.4MMay 12, 2026
David MountcastleEVP & Chief Financial Officer–$3.7MJul 9, 2026
Edward C FargisEVP & General Counsel–$215KMar 9, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PRVA short interest

Low short interest. 3.1% of PRVA shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 15%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.90M PRVA shares were sold short, 3.1% of the shares outstanding, down 22.2% from the report before. At the average daily volume of 857,040 shares, buying them all back would take about 4.5 trading days (days to cover).

Shares short, % of all shares

3.05%May 15Oct 304.87%

Days to cover

4.5May 15Oct 306.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.90M3.05%-22%857,0404.5
Oct 15, 20265.01M3.92%-14%1.44M3.5
Sep 30, 20265.81M4.55%+19%1.35M4.3
Sep 15, 20264.90M3.84%-10%1.24M4.0
Aug 31, 20265.45M4.27%+3%867,2486.3
Aug 14, 20265.29M4.14%+38%1.55M3.4
Jul 31, 20263.84M3.00%+4%1.14M3.4
Jul 15, 20263.69M2.93%-1%1.11M3.3
Jun 30, 20263.72M2.95%+24%1.39M2.7
Jun 15, 20262.99M2.38%-10%1.02M2.9
May 29, 20263.33M2.64%-2%748,4824.4
May 15, 20263.39M2.69%+6%1.30M2.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Privia Health Group company events

Privia Health Group filed 8 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 18, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. Jul 7, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
  5. May 22, 2026VoteReported shareholder vote results. Filing
  6. May 7, 2026ResultsReleased financial results. Filing
  7. Feb 26, 2026ResultsReleased financial results. Filing
  8. Dec 8, 2025AnnouncementPreviously, on September 23, 2025, Privia Health Group, Inc. announced the entry into a definitive agreement to acquire an Accountable Care Organization business from Evolent Health, Inc. The transaction closed on December 5, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Privia Health Group financials

Famous investors that hold PRVA

4 of the 50 well-known investors we track reported holding PRVA in their latest 13F filing. The largest position is Steve Cohen's, worth $40.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 20262.04M$40.2M0.1%New
Jim Simons · Renaissance TechnologiesQ3 2026613,300$12.1M0.0%-3%
Ken Griffin · Citadel AdvisorsQ3 2026563,729$11.1M0.0%+1054%
Israel Englander · Millennium ManagementQ3 2026348,314$6.9M0.0%+30%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PRVA in the last 120 days.

FiledHolderFormStake
Oct 30, 2026Vanguard Capital Management13G5.1%
Oct 30, 2026Vanguard Capital Management13G5.1%
Oct 7, 2026FMR LLC13G/A5.0%
Oct 7, 2026FMR LLC13G/A5.0%

Questions about Privia Health Group, Inc. (PRVA) stock

Who owns the most PRVA stock?

The largest reported owner of Privia Health Group, Inc. (PRVA) is BlackRock, Inc., with 17.0% of the company. In total, 301 funds and institutions reported holding PRVA at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are PRVA insiders buying or selling?

In the last 12 months, PRVA insiders reported no open-market purchases and 40 sales worth $22.2M. The latest trade was on Jul 9, 2026. See every trade.

What is the short interest in PRVA?

As of Oct 30, 2026, 3.90M PRVA shares were sold short, 3.1% of the shares outstanding, down 22.2% from the report before. At the average daily volume of 857,040 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.

Which famous investors hold PRVA?

4 of the 50 well-known investors we track reported PRVA in their latest 13F filing, including Steve Cohen, Jim Simons, Ken Griffin. The largest position is worth $40.2M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.